TY  - CONF

T1  - The cost effectiveness of adalimumab (HUMIRA((R))) in UK patients with moderate to severe RA

JO  - ANNALS OF THE RHEUMATIC DISEASES

PY  - 2004/07/01

AU  - Bansback NJ

AU  - Brennan A

AU  - Sengupta N

AU  - Pang F

ED  - 

VL  - 63

SP  - 512

EP  - 513

Y2  - 2024/12/22

ER  -